| Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets I Cecchi, IA de la Rosa, E Menegatti, D Roccatello, E Collantes-Estevez, ... Autoimmunity reviews 17 (11), 1138-1149, 2018 | 114 | 2018 |
| Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients C Pérez-Sánchez, P Ruiz-Limón, MA Aguirre, Y Jiménez-Gómez, ... Journal of autoimmunity 82, 31-40, 2017 | 105 | 2017 |
| Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation P Ruiz-Limon, R Ortega, IA de la Rosa, M Del Carmen Abalos-Aguilera, ... Translational Research 183, 87-103, 2017 | 101 | 2017 |
| Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients C Perez-Sanchez, P Font-Ugalde, P Ruiz-Limon, C Lopez-Pedrera, ... Human molecular genetics 27 (5), 875-890, 2018 | 69 | 2018 |
| Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial C Pérez-Sánchez, MÁ Aguirre, P Ruiz-Limón, MC Ábalos-Aguilera, ... Arteriosclerosis, thrombosis, and vascular biology 37 (10), 1923-1932, 2017 | 65 | 2017 |
| Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients C Pérez-Sánchez, MA Aguirre, P Ruiz-Limón, N Barbarroja, ... Scientific Reports 6 (1), 31375, 2016 | 53 | 2016 |
| Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues I Arias De La Rosa, A Escudero‐Contreras, S Rodríguez‐Cuenca, ... Journal of internal medicine 284 (1), 61-77, 2018 | 41 | 2018 |
| Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome C Pérez-Sánchez, I Arias-de la Rosa, MÁ Aguirre, M Luque-Tévar, ... haematologica 103 (5), 908, 2018 | 41 | 2018 |
| Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation AM Patiño-Trives, C Pérez-Sánchez, L Pérez-Sánchez, M Luque-Tévar, ... Arteriosclerosis, thrombosis, and vascular biology 41 (9), 2417-2430, 2021 | 33 | 2021 |
| Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in rheumatoid arthritis P Ruiz-Limon, R Ortega-Castro, N Barbarroja, C Perez-Sanchez, C Jamin, ... Frontiers in immunology 10, 1111, 2019 | 30 | 2019 |
| Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies IA De la Rosa, C Perez-Sanchez, P Ruiz-Limon, A Patiño-Trives, ... Haematologica 105 (9), 2250, 2020 | 27 | 2020 |
| Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission IC Aranda-Valera, I Arias de la Rosa, R Roldán-Molina, ... Pediatric Rheumatology 18, 1-12, 2020 | 22 | 2020 |
| Integrative clinical, molecular, and computational analysis identify novel biomarkers and differential profiles of anti-TNF response in rheumatoid arthritis M Luque-Tévar, C Perez-Sanchez, AM Patiño-Trives, N Barbarroja, ... Frontiers in Immunology 12, 631662, 2021 | 20 | 2021 |
| Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy A Ibáñez-Costa, C Perez-Sanchez, AM Patiño-Trives, M Luque-Tevar, ... Annals of the Rheumatic Diseases 81 (1), 56-67, 2022 | 19 | 2022 |
| Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion C Pérez‐Sánchez, I Cecchi, N Barbarroja, AM Patiño‐Trives, ... Journal of Cellular and Molecular Medicine 23 (9), 6308-6318, 2019 | 19 | 2019 |
| Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis ML Ladehesa-Pineda, I Arias de la Rosa, C López Medina, ... Therapeutic advances in musculoskeletal disease 12, 1759720X20982837, 2020 | 18 | 2020 |
| Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis I Arias de la Rosa, P Font, A Escudero-Contreras, MD López-Montilla, ... Therapeutic Advances in Chronic Disease 11, 2040622320965067, 2020 | 18 | 2020 |
| Characterization of antiphospholipid syndrome atherothrombotic risk by unsupervised integrated transcriptomic analyses L Pérez-Sánchez, AM Patiño-Trives, MÁ Aguirre-Zamorano, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 865-877, 2021 | 14 | 2021 |
| Nonalcoholic fatty liver disease in inflammatory arthritis: relationship with cardiovascular risk N Barbarroja, M Ruiz-Ponce, L Cuesta-López, C Perez-Sanchez, ... Frontiers in Immunology 13, 997270, 2022 | 11 | 2022 |
| The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by … I Arias de la Rosa, MD López‐Montilla, C Román‐Rodríguez, ... Journal of Internal Medicine 291 (5), 676-693, 2022 | 10 | 2022 |
